Abstract:A diverse of chiral beta-lactam bridged analogues of combretastatin A-4 (CA-4), 3-substituted 1,4-diaryl-2-azetidinones, were asymmetrically synthesized and biologically evaluated, leading to identify a number of potent anti-proliferative compounds represented by 14b and 14c with IC50 values of 0.001-0.021 mu M, against four human cancer cell lines (A2780, Hela, SKOV-3 and MDA-MB-231). Structure-activity relationship (SAR) studies on all stereoisomers of 14b and 14c revealed that the absolute configurations of the chiral centers at 3- and 4-position were critically important for the activity and generally a trans configuration between the "A" and "B" rings is optimal. In addition, 14b and 14c displayed less cytotoxicity on normal human oviduct epithelial cells than malignant cells indicating good selectivity in vitro. Further biochemical evaluation and cocrystal structures with tubulin demonstrated that both compounds disrupted tubulin polymerization through interacting at the colchicine-binding site, suppressed angiogenesis in vitro and in vivo, blocked cell cycle progression at mitotic phase and induced cellular apoptosis. The in vivo assays verified that both compounds inhibited xenograft tumor growth in nude mice with acceptable therapeutic window, showing promising potentials for further clinical development. (C) 2017 Elsevier Masson SAS. All rights reserved.

ChemInform Abstract: 4,5‐Diaryl‐3‐aminopyrazole Derivatives as Analogues of Combretastatin A‐4: Synthesis and Biological Evaluation.

4,5-Diaryl-3-Aminopyrazole Derivatives As Analogs Of Combretastatin A-4: Synthesis And Biological Evaluation

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis And In Vitro Antitumor Activities Of 3,4-Diaryl Substituted Pyrrolones Derivatives

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.

Synthesis andin vitroAntitumor Activities of 3,4-Diaryl Substituted Pyrrolones Derivatives

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

ChemInform Abstract: Synthesis, Molecular Modeling and Biological Evaluation of 2‐(benzylthio)‐5‐aryloxadiazole Derivatives As Antitumor Agents.

Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility

Novel 5-Methyl-2,4-disubstitued-oxazole Derivatives: Synthesis and Anticancer Activity

ChemInform Abstract: Synthesis and Biological Evaluation of Novel N‐[3‐(4‐phenylpiperazin‐1‐yl)‐propyl]‐carboxamide Derivatives.

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis,characterization and Biological Activities of Nitrogen-Containing Combretastatin A-4 Derivatives

Design, Synthesis, Biological Evaluation and Cocrystal Structures with Tubulin of Chiral Β-Lactam Bridged Combretastatin A-4 Analogues As Potent Antitumor Agents.

4,5-Diaryl-3h-1,2-dithiole-3-thiones and Related Compounds As Combretastatin A-4/oltipraz Hybrids: Synthesis, Molecular Modelling and Evaluation As Antiproliferative Agents and Inhibitors of Tubulin

Synthesis and Antitumor Activity of Novel 4-Chloro-3-arylmaleimide Derivatives

[Synthesis and Antitumor Activity of Arylsubstituted Imidazolin-2-one Derivatives].